Your browser does not support JavaScript!
Category List
Mechanocardiogram Spectrum Measurement Technology Has Been Designated as the Feature Article in the March 2018 Issue of IEEE Journal of Biomedical and Health Informatics

Mechanocardiogram Spectrum Measurement Technology Has Been Designated as the Feature Article in the March 2018 Issue of IEEE Journal of Biomedical and Health Informatics

 

Graduate Institute of Medical Mechatronics

The article “Identification of Location Specific Feature Points in a Cardiac Cycle Using a Novel Seismocardiogram Spectrum System” authored by the research team of Distinguished Prof. Ming-Yih Lee, Chairperson of the Graduate Institute of Medical Mechatronics of Chang Gung University, has been designated as the feature article in the field of Sensor Informatics in the March 2018 issue of IEEE Journal of Biomedical and Health Informatics.  This journal is listed in the Science Citation Index (SCI) list. 

This article introduced the multi-channel mechanocardiogram spectrum measurement technology developed by Distinguished Prof. Lee’s research team who uncovered six specific feature points for identifying the abnormalities of mechano-electrical behaviour.  Four microelectromechanical accelerometer measurement modules (also known as G sensor) were placed at four valvular auscultation sites to detect and track the opening and closing of heart valves, heart blood flow pulses, and miniature vibrational signals from body surfaces of the four valvular auscultation sites.  Results based on these four measurements could be presented in a three-dimensional time-order figure.  Four feature points measuring heart valves could be used to determine the opening and closing of heart valves, heart blood flow pulse, and myo-cardiac contraction abnormalities.  This innovative technology is nonintrusive, nonradioactive, and painless.  In particular, uncovering six feature points to identify heart beat abnormalities was unprecedented.  Meanwhile, the team’s proposal for human trials has been approved by Chang Gung Memorial Hospital.  Clinical trials as well as data analyses are currently in progress.  This ingenious technology shall be implemented in tandem with Electrocardiogram to diagnose acute heart disease, valvular heart disease (VHD), and heart failure (HF).  The research team has been granted several patents in USA and Taiwan on this new apparatus.  Right now the team is seeking opportunities to commercialize this technology and transfer the technology to medical device manufacturers.  Furthermore, Impact Research, a British company, evaluated this technology and suggested that it should have a potentially positive significant impact on the health care industry globally.  Impact Research published a report to recommend this technology to 35,000 academic and research institutions, hospitals, and venture capital orgnizations.

Click Num  
  • Forward to friend
  • Print
  • Add to my favorie .
  • Share
Forward to friend
Please input CAPTCHA
Voice Play
refresh captcha